What is HC Wainwright’s Forecast for BioLineRx Q1 Earnings?
BioLineRx Ltd. (NASDAQ:BLRX – Free Report) – Analysts at HC Wainwright issued their Q1 2025 EPS estimates for BioLineRx in a research report issued on Monday, March 31st. HC Wainwright analyst J. Pantginis anticipates that the biotechnology company will post earnings of ($0.84) per share for the quarter. HC Wainwright has a “Buy” rating and […]
BioLineRx Ltd. (NASDAQ:BLRX – Free Report) – Analysts at HC Wainwright issued their Q1 2025 EPS estimates for BioLineRx in a research report issued on Monday, March 31st. HC Wainwright analyst J. Pantginis anticipates that the biotechnology company will post earnings of ($0.84) per share for the quarter. HC Wainwright has a “Buy” rating and […]
